Harvard University, Cambridge, Massachusetts, USA.
Center for Global Health, Center for Clinical Epidemiology and Biostatistics, and Department of Dermatology, University of Pennsylvania Perelman School of Medicine and Florida Center for Dermatology, PA, St Augustine, Florida, USA
BMJ Open. 2021 Jul 14;11(7):e043758. doi: 10.1136/bmjopen-2020-043758.
To develop and validate the Oxford Pandemic Attitude Scale-COVID-19 (OPAS-C), a multidimensional scale that addresses seven domains over 20 items including stress, fear, loneliness, sense of community, belief that the pandemic is a hoax or exaggerated, the use of and attitude to non-pharmaceutical interventions and vaccine hesitancy, in a single measure.
Cross-sectional validation study.
Internet based with respondents in the USA and UK.
General community respondents using the Prolific Academic platform.
Exploratory factor analyses with promax oblique rotation and confirmatory factor analysis including goodness of fit indices: root mean square error of approximation (RMSEA), standardised root mean square residual (SRMR) and comparative fit index (CFI). Reliability as internal consistency using Cronbach's alpha. Convergent and discriminant validity using Pearson correlation coefficients.
The sample included 351 respondents in the USA and the factorial structure was confirmed using a separate set of 348 respondents in the UK. The OPAS-C had excellent goodness of fit characteristics, with an RMSEA of 0.047 (90% CI 0.037 to 0.056), SRMR of 0.043 and CFI of 0.962. Reliability was excellent, demonstrating Cronbach's alpha of 0.87 in both the US and UK samples. Convergent validity showed correlation coefficients of 0.54 and 0.49 in the US and UK samples, respectively. Discriminant validity demonstrated correlations of 0.21 and 0.26 in the US and UK samples, respectively.
The OPAS-C represents the first validated scale that addresses mental health measures and public health-relevant responses to COVID-19, and may be a useful measure for use in future longitudinal and cross-sectional studies. Further international validation beyond the USA and UK may be helpful.
开发和验证牛津大流行态度量表-COVID-19(OPAS-C),这是一种多维量表,通过 20 个项目涵盖七个领域,包括压力、恐惧、孤独、社区意识、认为大流行是骗局或夸大其词、非药物干预和疫苗犹豫的使用和态度,在单一措施中。
横断面验证研究。
基于互联网,受访者来自美国和英国。
使用 Prolific Academic 平台的普通社区受访者。
探索性因素分析采用 promax 斜交旋转和验证性因素分析,包括拟合优度指数:均方根误差近似值(RMSEA)、标准化均方根残差(SRMR)和比较拟合指数(CFI)。使用 Cronbach 的 alpha 进行可靠性作为内部一致性。使用 Pearson 相关系数进行收敛和判别有效性。
该样本包括 351 名来自美国的受访者,其因子结构在美国使用一组 348 名来自英国的受访者进行了确认。OPAS-C 具有出色的拟合优度特征,RMSEA 为 0.047(90%CI 0.037 至 0.056),SRMR 为 0.043,CFI 为 0.962。可靠性非常好,在美国和英国的样本中,Cronbach 的 alpha 分别为 0.87。收敛有效性显示,美国和英国样本的相关系数分别为 0.54 和 0.49。判别有效性显示,美国和英国样本的相关系数分别为 0.21 和 0.26。
OPAS-C 代表了第一个经过验证的量表,该量表涵盖了与心理健康措施和与 COVID-19 相关的公共卫生反应,并且可能是未来纵向和横断面研究的有用测量工具。除美国和英国以外,在国际范围内进行进一步验证可能会有所帮助。